Article Text

other Versions

PDF
Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
  1. Koshi Nakamura (knaka{at}kanazawa-med.ac.jp)
  1. Kanazawa Medical University, Japan
    1. Federica Barzi
    1. The George Institute for International Health, Australia
      1. Rachel Huxley
      1. The George Institute for International Health, Australia
        1. Tai-Hing Lam
        1. University of Hong Kong, Hong Kong
          1. Il Suh
          1. Yonsei University College of Medicine, Korea, Republic of
            1. Jean Woo
            1. Chinese University of Hong Kong, Hong Kong
              1. Hyeon Chang Kim
              1. Yonsei University College of Medicine, Korea, Republic of
                1. Valery L Feigin
                1. University of Auckland, New Zealand
                  1. Dongfeng Gu
                  1. Chinese Academy of Medical Sciences and Peking Union Medical College, China
                    1. Mark Woodward
                    1. Mount Sinai Medical Center, United States

                      Abstract

                      Objective: To explore whether an interaction between smoking and serum total cholesterol (TC) and/or decreased levels of serum high-density lipoprotein cholesterol (HDLC) exists for any major subtype of cardiovascular diseases.

                      Design: An individual participant overview of 34 cohort studies.

                      Setting: The Asia-Pacific region.

                      Participants: People aged 20 years or more without a particular condition or risk factor.

                      Mean outcome measures: Hazard ratios (HRs) and 95% confidence intervals (CIs) for both TC and HDLC by smoking status were estimated using Cox proportional hazard models adjusted for age and systolic blood pressure and stratified by study and sex.

                      Results: During follow-up (median 4.0 years), 3,298 coronary heart disease (CHD) and 4,318 stroke events were recorded. For CHD, the HR (95% CI) for an additional 1.06 mmol/L increment in TC was greater in current smokers than in non-smokers: 1.54 (1.43 to 1.66) versus 1.38 (1.30 to 1.47); p = 0.02. Similarly, the HR (95% CI) for an additional 0.40 mmol/L decrement in HDLC was greater in current smokers than in non-smokers: 1.67 (1.35 to 2.07) versus 1.28 (1.10 to 1.49); p = 0.04. The positive association of TC with ischaemic stroke, and the negative association of TC with haemorrhagic stroke, were broadly similar for current smokers and non-smokers. Similarly, the risks of both the subtypes of stroke remained broadly unchanged as HDLC decreased in both current smokers and non-smokers.

                      Conclusions: Smoking exacerbated the effects of both TC and HDLC on CHD, although no interaction between smoking and TC or HDLC existed for either of the subtypes of stroke.

                      Statistics from Altmetric.com

                      Request permissions

                      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.